secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2024-05-28T23:59:59+00:00
Accession:  0000950170-24-065371
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus shareholders approve 2.93M share increase to stock option plan
-----------------------------------------------------------------------

- Stockholders approved an amendment increasing shares reserved under the stock option plan by 2,931,820 shares.
- Evergreen provision raised from 4% to 5% of outstanding shares annually through 2028; plan expiration extended to March 14, 2034.
- Class III directors Leon O. Moulder Jr. and Alison F. Lawton elected; advisory votes on executive compensation approved with 23.0M votes for, 26.8K against.
- Stockholders ratified Deloitte as independent auditor for FY2024 with 24.1M votes for.
- Advisory vote on executive compensation frequency set to every year based on 23.0M votes for one-year interval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000095017024065371/0000950170-24-065371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000095017024065371/dnth-20240523.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-065371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer